Skip to main content
. Author manuscript; available in PMC: 2010 Oct 14.
Published in final edited form as: Arch Dermatol. 2009 Jan;145(1):63–66. doi: 10.1001/archdermatol.2008.521

Table.

Reported Cases of Thyroid Disease and Diabetes Following Drug Hypersensitivity Syndrome (DHS)

Case Endocrinopathy Time From DHSa Drug Therapyb Antibodies Comments
114 Fulminant diabetes 2 wk Carbamazepine Islet cell/GAD negative
215 Fulminant diabetes 0 d Mexiletine GAD negative Preexisting type 2 diabetes mellitus, concurrent pancreatitis
316 Fulminant diabetes 7 d Allopurinol Not reported Concurrent pancreatitis
417 Fulminant diabetes 2.5 mo Penicillin, diclofenac, ibuprofen Islet cell/GAD negative
518 Type 1 diabetes mellitus 4 mo Methimazole GAD positive
6 Type 1 diabetes mellitus 7 mo Minocycline GAD positive, IA2 positive Our patient
719 Hyperthyroidism 0 d Minocycline TPO, TG, TSI negative Lupuslike syndrome, not DRESS
820 Hypothyroidism 4 wk Phenytoin TPO positive
920 Hypothyroidism 4 wk Salazopyrin TPO positive
1020 Hypothyroidism 8 wk Phenobarbital TPO positive
1120 Hypothyroidism 8 wk Phenobarbital, carbamazepine unknown
1220 Hypothyroidism Unknown Phenytoin, phenobarbital, carbamazepine TPO negative
13 Hyperthyroidism 7 wk Minocycline TPO, TG, TSI, TSHR positive Our patient

Abbreviations: DRESS, drug reaction with eosinophilia and systemic symptoms; GAD, glutamic acid decarboxylase; TG, thyroglobulin; TPO, thyroid peroxidase; TSHR, thyrotropin-receptor; TSI, thyroid-stimulating immunoglobulin.

a

Time between presentation of DHS and presentation of endocrinopathy.

b

Minocycline administered as minocycline hydrochloride.